Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
Titel:
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
Auteur:
Kityo, Cissy Mambule, Ivan K Musaazi, Joseph Sokhela, Simiso Mugerwa, Henry Ategeka, Gilbert Cresswell, Fiona Siika, Abraham Kosgei, Josphat Shah, Reena Naidoo, Logashvari Opiyo, Kimton Otike, Caroline Möller, Karlien Kaimal, Arvind Wambui, Charity Van Eygen, Veerle Mohammed, Perry Addo Boateng, Fafa Paton, Nicholas I